fda approved indications for glp 1 and fda glp 1 Over the last 6 years as a metabolic clinical research investigator glp-1 fda approved indications How

doi:10.3945/an.111.001743 Institute of Medicine

When combined with diet and physical activity changes, brand-name Wegovy is approved by the Food and Drug Administration (FDA) for the following purposes: Weight loss in patients 12 years or older with obesity Body weight reduction in adults who are overweight and have at least one weight-related condition, such as high blood pressure, obstructive sleep apnea (OSA), or Type 2 diabetes Cardiovascular risk reduction in adults with heart disease and either obesity or overweight Treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis Wegovy is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist)

Jones-Leone, R

Given as simple once-weekly weight loss injections, they are prescribed only after our providers determine which is right for you based on your labs and metabolic profile